Rox Medical has announced the enrolment of the first two Irish patients, at Beaumont and Mater Private Hospitals, in the CONTROL-HTN randomised controlled trial of its Rox Flow procedure for the treatment of resistant hypertension.
Royal Philips Electronics has announced that it has received 510(k) clearance from the FDA to market its EchoNavigator live image-guidance tool, which is designed to help interventional cardiologists and cardiac surgeons to perform minimally-invasive structural heart disease repairs by providing an integrated view of live X-ray and 3D ultrasound images.
The online meeting registration is open for the Society of Interventional Radiology s Annual Scientific Meeting 13–18 April at the Ernest N Morial Convention Center in New Orleans, USA. “The meeting s theme, “Interventional Radiology reaching out,” illustrates the many ways the Annual Scientific Meeting provides valuable education to attendees across a broad range of diverse clinical interests and practice settings,” said Gary P Siskin, professor and chair of the department of radiology, Albany Medical College, Albany, New York, USA, and the meeting s scientific programme chair. “Annual Scientific Meeting attendees come from all areas: they are community or university-based physicians, physician assistants, nurse practitioners and radiology assistants, nurses, technologists, hospital administrators and industry partners. To complement our theme of inclusion, we have designed sessions that will meet the educational needs of all these various groups,” Siskin added.
Surefire Medical’s new infusion system maximises delivery of drugs directly to the tumour site while minimising potential damage to non-target organs, according to a new study. The ability to more safely and efficiently deliver embolic agents to target tumours locally marks a significant advance in radiation oncology procedures and in the treatment of liver cancer.
ReCor Medical has announced the start of ACHIEVE, a 50-patient post-market study of the company’s CE marked next-generation, ultrasound-based renal denervation system (Paradise) that will be conducted across multiple sites in Europe. According to a company press release, the Paradise system is a minimally invasive 6Fr over-the-wire ultrasound device for treating resistant hypertension. The first two patients in the study have been enrolled at the Thoraxcenter, Rotterdam, The Netherlands. Both patients were treated quickly with no device or procedural complications.
St Jude Medical, the company behind the Enlightn renal denervation system, has announced that its new study—Enlightnment—will investigate the long-term effects of renal denervation in patients with resistant hypertension to see if the treatment can reduce the risk of major cardiovascular events (such as myocardial infarction) as well as lower blood pressure.
On the 26 February 2013 Surefire Medical, the developer of a new class of infusion systems designed to maximise targeted delivery of embolization agents without reflux, announced CE mark approval for its Surefire Infusion System ST/LT and Surefire Specialty Catheters. The company will launch its latest products in Europe during the second quarter 2013.
The Diagnostic Center for Disease, Florida, USA, in conjunction with PanAm HIFU, announced data results on 5 March 2013 showing a 95% cure rate with high intensity focused ultrasound (HIFU) in more than 200 patients at more than 7 years post treatment.
On 1 March 2013, Coding Strategies, who produce consulting and education for physician and outpatient medical coding, compliance and ICD-10-CM for specialty-specific content, launched this week two new resources dedicated to radiology and oncology HCPCS codes—the HCPCS Radiology Resource and the HCPCS Oncology Resource. According to the company, these easy-to-use reference tools are designed to provide quick access to the HCPCS codes for radiology or infusion centre practices and departments.
A study led by Masafumi Ikeda, National Cancer Center Hospita, Kashiwanoha, Kashiwa Chiba, Japan, and published in the Journal of Vascular and Interventional Radiology, has investigated transcatheter arterial chemoembolization (TACE) with emulsion of lipidol and anthracycline agent and gelatin sponge particles for hepatocellular carcinoma.
Siddharth A Padia, University of Washington Medical Center, Seattle, USA, and colleagues, stated that, although transarterial chemoembolization is a standard treatment for hepatocellular carcinoma, “wide variability in techniques has led to varying practices and results across institutions.”
Terumo Interventional Systems, a business unit of Terumo Medical Corporation, today announced the launch of a new, dedicated group focused on direct sales, marketing, support and distribution of key products to the urological specialty beginning April 1, 2013.
Covidien announced on 20 February 2013 the completion of patient enrolment in its iliac stent clinical study series. The series is composed of two prospective, multinational, multicentre studies—VISIBILITY Iliac and DURABILITY Iliac.
Sirtex Medical Limited (ASX: SRX) today announced half year results that demonstrate another strong financial performance over the reporting period and continued dose sales growth of its SIRSpheres ® microspheres targeted radiotherapy treatment for liver cancers.
Terumo Medical Corporation (Terumo), today announced that it has filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co., Ltd in the U.S. District Court of New Jersey.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos